Transtek(SZ:300562) Sou Hu Cai Jing·2026-01-07 19:05Group 1 - The core stock price of Leksin Medical (300562) closed at 13.93 yuan on January 7, 2026, down by 1.42% with a turnover rate of 3.6% and a trading volume of 58,300 shares, amounting to a transaction value of 81.63 million yuan [1][2] - On January 7, the net outflow of main funds was 1.12 million yuan, while the net inflow of speculative funds was 3.60 million yuan, and the net outflow of retail funds was 2.48 million yuan [2] Group 2 - Leksin Medical announced the use of idle raised funds totaling 129 million yuan to purchase principal-protected floating income structured deposits, which are linked to the AUD/USD exchange rate, with a term until April 15, 2026, and an expected annual yield of 0.50% to 1.80% [1][2] - The company has completed the necessary approval procedures from the board of directors, supervisory board, and shareholders' meeting for this investment, ensuring that the use of raised funds remains unaffected [1] - The company has implemented multiple measures to control investment risks, including tracking project progress, internal audit supervision, and information disclosure [1]